Skip to main content
OpenTrials
Completed

NCT Number: NCT04890470

Effects of Oxytocin and Vasopressin on Moral Decision Making

To determine whether the neuropeptide oxytocin (OXT) and vassopressin (AVP) influence moral decision making

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Diabetes Insipidus Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Pituitary Diseases Urogenital Diseases Urologic Diseases

Age range

18 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Xiaoxiao Zheng

Sichuan, 611731, China

About this study

In a double-blind, between- subject placebo (PLC) controlled design, subjects will first complete a series of questionnaires in terms of mood, clinical symptoms, and traits. After that their moral judgment and emotion towards both verbal descriptions of moral dilemma scenarios and pictures of specific interpersonal ones will be assessed and the effect of intranasal OXT and AVP between both male and female healthy subjects will be investigated.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy subjects without past or current psychiatric or neurological disorders

Exclusion criteria

  • pregnancy

Treatment and study plan

Oxytocin

Drug

intranasal administration of oxytocin (24 IU)

Vasopressin

Drug

intranasal administration of vasopressin (20 IU)

Placebo

Drug

intranasal administration of placebo

Primary outcomes

  1. Effect of OXT and AVP on behavioral index of moral decision task

    Time frame: 45 mins - 105 mins

    intensity of feelings

Sponsors and collaborators

Lead sponsor

University of Electronic Science and Technology of China

Other

Registry information

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
May 18, 2021
Registry last updated
Sep 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.